Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2006 | 1 |
2007 | 1 |
2016 | 1 |
2017 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Yttrium 90 ibritumomab tiuxetan in lymphoma.
Leuk Lymphoma. 2006 Jun;47(6):967-77. doi: 10.1080/10428190600572582.
Leuk Lymphoma. 2006.
PMID: 16840185
Review.
Initial studies of 90Y-ibritumomab tiuxetan in non-Hodgkin's lymphoma (NHL) have suggested benefit in patients with relapsed or refractory indolent disease. However, the routine adoption of this agent is tempered by concerns of associated toxicities and unclear long-term b …
Initial studies of 90Y-ibritumomab tiuxetan in non-Hodgkin's lymphoma (NHL) have suggested benefit in patients with relapsed or refractory i …
Rituximab in lymphoma: a systematic review and consensus practice guideline from Cancer Care Ontario.
Cheung MC, Haynes AE, Meyer RM, Stevens A, Imrie KR; Members of the Hematology, Disease Site Group of the Cancer Care Ontario Program in Evidence-Based Care.
Cheung MC, et al.
Cancer Treat Rev. 2007 Apr;33(2):161-76. doi: 10.1016/j.ctrv.2006.10.005. Epub 2007 Jan 22.
Cancer Treat Rev. 2007.
PMID: 17240533
Review.
A comprehensive literature search was completed by reviewers from the Hematology Disease Site Group of Cancer Care Ontario. Data were abstracted from randomized controlled trials of rituximab-containing regimens for patients with non-Hodgkin's lymphoma …
A comprehensive literature search was completed by reviewers from the Hematology Disease Site Group of Cancer Ca …
Item in Clipboard
Rituximab in Lymphoma and Chronic Lymphocytic Leukaemia: A Practice Guideline.
Prica A, Baldassarre F, Hicks LK, Imrie K, Kouroukis T, Cheung M; Members of the Hematology Disease Site Group of the Cancer Care Ontario Program in Evidence-based Care.
Prica A, et al.
Clin Oncol (R Coll Radiol). 2017 Jan;29(1):e13-e28. doi: 10.1016/j.clon.2016.09.004. Epub 2016 Oct 14.
Clin Oncol (R Coll Radiol). 2017.
PMID: 27746042
A comprehensive literature search was completed by a methodologist from the Hematology Disease Site Group of Cancer Care Ontario. Data were extracted from randomised controlled trials of rituximab-containing chemotherapy regimens for patients with lymp …
A comprehensive literature search was completed by a methodologist from the Hematology Disease Site Group of Can …
Item in Clipboard
Cite
Cite